Increase in the peripheral lymphocyte populations expressing CD54 (ICAM-1) after hyperthermic isolated limb perfusion in patients with malignant melanoma: an analysis of four cases.

[1]  R. Tominaga,et al.  Kinetics of immunological parameters in patients with malignant melanoma treated with hyperthermic isolated limb perfusion. , 1997, Journal of dermatological science.

[2]  T. Kageshita,et al.  Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro. , 1996, Pigment cell research.

[3]  J. Nakayama,et al.  Two Cases of Metastatic Malignant Melanoma of the Lower Limb Treated with Hyperthermic Isolated Limb Perfusion and Concomitant Infusion of Either Carboplatin or β‐Interferon , 1996, The Journal of dermatology.

[4]  H. Eguchi.  The effect of INF-β on the expression of ICAM-1 (Intercellular Adhesion Molecule-1) on melanoma cells in vitro and in vivo , 1992 .

[5]  J. Becker,et al.  Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. , 1991, Journal of immunology.

[6]  R. Supino,et al.  Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive ability , 1990, International journal of cancer.

[7]  P. Schlag,et al.  Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  J. Thomas,et al.  Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb , 1990, The British journal of surgery.